{name}
{subtitle}
A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
city
~7 mi. (Thessaloníki, Greece, +192 more cities)
facility
European Interbalkan Medical Center, +1 more facility
biomarker
ER Positive, +1 more biomarker
drug
abemaciclib, +1 more drug
drug type
hormone therapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
city
~7 mi. (Thessaloníki, Greece, +130 more cities)
facility
Antikarkiniko Nosokomeio Thessalonikis THEAGENIO ( Site 0303)
drug
BCG solution, +1 more drug